Novum Pharmaceutical Research Services and Lambda Therapeutic Research are exhibiting at CPHI Milan 2026, taking place from 6-8 October 2026 at Fiera Milano, Italy. Meet us at Booth B68 (Hall 18) to discover how our Global Full-service CRO and Biologics CDMO capabilities support pharmaceutical, biotechnology, and generic drug companies across the entire drug development lifecycle.
Whether you’re advancing a new chemical entity (NCE), biologic, biosimilar, peptide, or complex generic, our experienced scientific teams provide integrated, regulatory-compliant solutions tailored to your development goals.
Why Meet Lambda & Novum?
- Experience of 8,500+ PK/PD studies and 300+ multicentre late phase clinical trials
- 1,600+ validated bioanalytical assays, supported by advanced LC-MS/MS platforms, including SCIEX 7500+
- Expertise in regulated large molecule bioanalysis
- Extensive experience supporting biologics, biosimilars, peptides, and other complex molecules
- Specialized capabilities in First-in-Human, inhalation, euglycemic clamp, and transdermal studies
- Full-service CRO capabilities spanning Phase I through Phase IV, supported by integrated central laboratory, medical imaging, biometrics, regulatory affairs, pharmacovigilance, and medical writing services
- Successful regulatory inspections by US FDA, EMA, MHRA, ANVISA, NPRA, and other global health authorities
- New cGMP Biologics CDMO facility in Ahmedabad, India
Our Integrated Service Portfolio
- Early Phase Clinical Trials
- Late Phase Clinical Trials
- Bioanalytical Services
- Biosimilar Development
- Central Clinical Laboratory Services
- Medical Imaging
- Biostatistics & Data Management
- Pharmacovigilance
- Regulatory Affairs
- Medical Writing
- Biologics CDMO Services
With operations across India, USA, Canada, UK, Spain, and Poland, Lambda & Novum deliver seamless global support through experienced scientific teams, integrated service delivery, and a proven regulatory track record.
Whether you’re planning your next clinical trial, advancing a biologics or biosimilar program, or looking for an integrated development partner, we look forward to discussing how our integrated CRO and Biologics CDMO capabilities can help accelerate your development strategy.
Schedule a Meeting
Book a meeting with our experts during CPHI Milan 2026 to discuss your upcoming clinical development, bioanalytical, or biologics programs.
Email: or complete the enquiry form, and our team will get in touch to schedule a meeting.